SCHEMBL587215

SCHEMBL587215

COC(=O)C1CCN(C(=O)OC)C(Cc2ccccc2F)C1.COC(=O)N1CCC(C(=O)O)CC1Cc1ccccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
NPSR1 Q6W5P4 3/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TACR1 P25103 1/20 0.38
NOTUM Q6P988 1/20 0.38
MAPK1 P28482 1/20 0.38
PKM P14618 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
OPRK1 P41145 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 3/20 0.37
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
DPP7 Q9UHL4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL586962 0.96 ALDH1A1 (0.42) ALDH1A1NPSR1MAPTHPGDHSD17B10
SCHEMBL581906 0.96 NOTUM (0.41) ALDH1A1NPSR1MAPTHPGDHSD17B10
SCHEMBL587414 0.84 SMN1; SMN2 (0.42) ALDH1A1NPSR1MAPTHPGDHSD17B10
SCHEMBL580897 0.84 SMN1; SMN2 (0.39) ALDH1A1NPSR1MAPTHPGDHSD17B10
SCHEMBL580959 0.83 NOTUM (0.45) ALDH1A1KMT2ANOTUMPKMKDM4E
SCHEMBL586492 0.83 DPP4 (0.49) ALDH1A1NPSR1MAPTHPGDHSD17B10
SCHEMBL582105 0.83 ALDH1A1 (0.45) ALDH1A1NOTUMPKMDPP4DPP8
SCHEMBL581500 0.83 DPP4 (0.43) ALDH1A1NOTUMSMN1; SMN2DPP4DPP8
SCHEMBL586861 0.83 ALDH1A1 (0.47) ALDH1A1NPSR1MAPTHPGDHSD17B10
SCHEMBL587229 0.82 KDM4E (0.48) ALDH1A1NPSR1MAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2417131-A1 ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS AstraZeneca AB (SE) 2012-02-15 EP disclosed
WO-2010117323-A1 METHOD AND APPARATUS FOR PRODUCING HEAT ENERGY AND CARBON DIOXIDE ASTRAZENECA AB (SE) 2010-10-14 WO disclosed